Testing effectiveness (Phase 2)Not Yet RecruitingNCT07812181
What this trial is testing
An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression Disorder
Who this might be right for
Down Syndrome Regression Disorder (DSRD)Down Syndrome (Trisomy 21)Neuroinflammatory / Neuropsychiatric Disorder
Jonathan Santoro 20